JP2012530765A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530765A5
JP2012530765A5 JP2012516757A JP2012516757A JP2012530765A5 JP 2012530765 A5 JP2012530765 A5 JP 2012530765A5 JP 2012516757 A JP2012516757 A JP 2012516757A JP 2012516757 A JP2012516757 A JP 2012516757A JP 2012530765 A5 JP2012530765 A5 JP 2012530765A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
unsubstituted
alkoxy
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012516757A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530765A (ja
JP5685247B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/059044 external-priority patent/WO2010149761A1/en
Publication of JP2012530765A publication Critical patent/JP2012530765A/ja
Publication of JP2012530765A5 publication Critical patent/JP2012530765A5/ja
Application granted granted Critical
Publication of JP5685247B2 publication Critical patent/JP5685247B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012516757A 2009-06-25 2010-06-25 結核を処置するための組成物 Active JP5685247B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09163765 2009-06-25
EP09163765.2 2009-06-25
PCT/EP2010/059044 WO2010149761A1 (en) 2009-06-25 2010-06-25 Composition for treatment of tuberculosis

Publications (3)

Publication Number Publication Date
JP2012530765A JP2012530765A (ja) 2012-12-06
JP2012530765A5 true JP2012530765A5 (enExample) 2013-08-08
JP5685247B2 JP5685247B2 (ja) 2015-03-18

Family

ID=41128169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012516757A Active JP5685247B2 (ja) 2009-06-25 2010-06-25 結核を処置するための組成物

Country Status (5)

Country Link
US (1) US8912329B2 (enExample)
EP (1) EP2445495A1 (enExample)
JP (1) JP5685247B2 (enExample)
CN (1) CN102458393B (enExample)
WO (1) WO2010149761A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000064A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
FR3000065A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
CN105189478B (zh) 2013-01-07 2019-10-22 南加州大学 脱氧尿苷三磷酸酶抑制剂
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
US10570100B2 (en) 2015-07-08 2020-02-25 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
JP6836589B2 (ja) 2015-07-08 2021-03-03 シーブイ６ セラピューティクス （エヌアイ） リミテッド ヒダントインを含むデオキシウリジントリホスファターゼ阻害剤
WO2017006283A1 (en) 2015-07-08 2017-01-12 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
US11168059B2 (en) 2016-11-23 2021-11-09 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
US11174271B2 (en) 2016-11-23 2021-11-16 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
WO2018098207A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
US10858344B2 (en) 2016-11-23 2020-12-08 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018128720A1 (en) 2017-01-05 2018-07-12 Cv6 Therapeutics (Ni) Limited Uracil containing compounds
CN108624641A (zh) * 2018-04-10 2018-10-09 佛山科学技术学院 一种通过合成生物学制备乙硫异烟胺烟酰胺腺嘌呤二核苷酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872448A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-acyl-3 substituted azetidines
GB872488A (en) 1959-01-19 1961-07-12 Nat Res Dev Improvements in or relating to voltage-measuring circuits
DE4127111A1 (de) 1990-08-24 1992-02-27 Basf Ag Verfahren zur herstellung von 3-pyrrolin-2-onen
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
MXPA06012932A (es) 2004-05-07 2007-01-26 Janssen Pharmaceutica Nv Derivados de pirrolidin-2-ona y piperidin-2-ona como inhibidores de 11-beta hidroxiesteroide deshidrogenasa.
FR2903405B1 (fr) 2006-07-04 2011-09-09 Pasteur Institut Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009080432A2 (en) 2007-12-21 2009-07-02 Eth Zurich Composition for treatment of tuberculosis
DE102007062691A1 (de) * 2007-12-21 2009-06-25 Beiersdorf Ag Wirkstoffkombinationen aus Anisfruchtextrakt und einem oder mehreren 2,3-Dibenzylbutyrolactonen

Similar Documents

Publication Publication Date Title
JP2012530765A5 (enExample)
JP2008520742A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
EA201290260A1 (ru) Бензимидазол-имидазольные производные
JP2008526724A5 (enExample)
JP2009533410A5 (enExample)
JP2010525023A5 (enExample)
JP2006517572A5 (enExample)
JP2008517926A5 (enExample)
JP2011518811A5 (enExample)
JP2011529054A5 (enExample)
KR20090043506A (ko) 에티온아미드 활성 강화 효과를 갖는 화합물 및 그 용도
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
JP2014530900A5 (enExample)
JP2011515462A5 (enExample)
BR122017003181A2 (pt) composto inibidor de trk, composição farmacêutica e medicamento compreendendo dito composto e seu uso para profilaxia e/ou terapia de doença relacionada à trk e/ou para inibir trk
NZ627750A (en) Carbamate compounds and of making and using same
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
MXPA05010816A (es) Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer.
JP2012507535A5 (enExample)
RU2010145463A (ru) Производные замещенного 2-фенилпиридина
JP2013539786A5 (enExample)
JP2006507247A5 (enExample)
JP2020512400A5 (enExample)